Biblio

Export 191 results:
Filters: Author is Roy, Marc-André  [Clear All Filters]
2022
Brodeur S, Vanasse A, Courteau J, Courteau M, Stip E, Fleury M-J, Lesage A, Demers M-F, Roy M-A. Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach. Acta Psychiatrica ScandinavicaActa Psychiatrica ScandinavicaActa Psychiatr Scand [Internet]. 2022;n/a(n/a). https://doi.org/10.1111/acps.13411
Brodeur S, Courteau J, Vanasse A, Courteau M, Stip E, Fleury M-J, Lesage A, Demers M-F, Corbeil O, Béchard L, Roy M-A. Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study. Br J Psychiatry. 2022;:1-8.
Brodeur S, Vanasse A, Courteau J, Stip E, Lesage A, Fleury M-J, Courteau M, Roy M-A. Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational Study. Acta Psychiatr Scand. 2022;.
LeBlanc A, Baron M, Blouin P, Tarabulsy G, Routhier F, Mercier C, Després J-P, Hébert M, De Koninck Y, Cellard C, Collin-Vézina D, Côté N, Dionne É, Fleet R, Gagné M-H, Isabelle M, Lessard L, Menear M, Merette C, Ouellet M-C, Roy M-A, Saint-Jacques M-C, Savard C. For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: the MAVIPAN longitudinal prospective cohort study protocol. BMJ Open. 2022;12(4):e048749.
Béchard L, Corbeil O, Thivierge M-A, Assaad I, Boulanger C, Mailhot M-P, Turgeon-Fournier A, Roy M-A, Demers M-F. Management of Rhabdomyolysis in a Patient Treated with Clozapine: A Case Report and Clinical Recommendations. Clin Psychopharmacol Neurosci. 2022;20(1):194-198.
Lesage A, Courteau J, Brodeur S, Stip E, Fleury M-J, Courteau M, Roy M-A, Vanasse A. Urbanicity, Schizophrenia and Equitable Specialist Services Allocation. Can J Psychiatry. 2022;67(2):160-161.